Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention

Author： Smith Simon M.G. Judge Heather M. Peters Gary Storey Robert F.

Publisher： Informa Healthcare

ISSN： 1369-1635

Source： Platelets, Vol.15, Iss.8, 2004-12, pp. : 465-474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention

By Barillà Francesco

Platelets, Vol. 24, Iss. 3, 2013-05 ,pp. : 183-188

Informa Healthcare

Access to resources Recommend Favorite

Relation between the Change in Mean Platelet Volume and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention

Current Vascular Pharmacology, Vol. 13, Iss. 5, 2015-01 ,pp. : 687-693

Bentham Science Publishers

Access to resources Recommend Favorite

Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention

By Saucedo Jorge

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 2, 2010-08 ,pp. : 200-209

Springer Publishing Company

Access to resources Recommend Favorite

Significance of Aspirin and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Interventions

Current Vascular Pharmacology, Vol. 5, Iss. 2, 2007-04 ,pp. : 135-140

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of High‐Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta‐analysis

Clinical Cardiology, Vol. 38, Iss. 11, 2015-11 ,pp. : 668-678

John Wiley & Sons Inc

Access to resources Recommend Favorite